{"disease":{"id":"chronic-hbv-infection","name":"chronic hbv infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07274345","title":"Prevalence and Risk Factors of Antiviral Resistance in Egyptian HBV Patients","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Amira Mohamed Zidan","has_results":false},{"nct_id":"NCT05792761","title":"A Study on Antiviral Treatment of Chronic Hepatitis B in Children","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1900,"lead_sponsor_name":"Fang Wang","has_results":false},{"nct_id":"NCT06874127","title":"Non-Invasive Model for Fibrosis Regression in HBV Patients","phase":"","overall_status":"RECRUITING","enrollment_count":1100,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT03903796","title":"Study of the Efficacy and Safety of HS-10234 in Patients With Chronic Hepatitis B Virus Infection","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":963,"lead_sponsor_name":"Jiangsu Hansoh Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06906016","title":"New HBV Infection Biomarkers: Clinical Characterization and Impact on Management","phase":"","overall_status":"RECRUITING","enrollment_count":900,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT03909191","title":"Serum HBV RNA Value on Chronic Hepatitis B Virus Infection Manage","phase":"","overall_status":"COMPLETED","enrollment_count":454,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT04147208","title":"Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":250,"lead_sponsor_name":"Sunshine Lake Pharma Co., Ltd.","has_results":false},{"nct_id":"NCT02836249","title":"Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Positive Hepatitis B (China)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":181,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT01943799","title":"Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":178,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT06990438","title":"Effect of Long-Term Use of Tenofovir (TDF) on Bone Density in Patients With Chronic Hepatitis B","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":172,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT06896630","title":"Effect of Tenofovir (TDF) on Renal Function in Patients With Chronic Hepatitis B","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":172,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT02836236","title":"Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Negative Hepatitis B (China)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":155,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT04008004","title":"A Study of EDP-514 in Healthy Subjects (Part 1) and Patients With Chronic Hepatitis B Virus Infection (Part 2)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":99,"lead_sponsor_name":"Enanta Pharmaceuticals, Inc","has_results":false},{"nct_id":"NCT05468060","title":"Study of the Safety, Tolerability, Pharmacokinetic Characteristics of PA1010 in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Zhejiang Palo Alto Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT05734807","title":"A Study to Evaluate the Antiviral Activity and Safety of HH-003 in Chronic Hepatitis B Subjects With Low-level Viremia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":74,"lead_sponsor_name":"Huahui Health","has_results":false},{"nct_id":"NCT05542979","title":"A Study to Evaluate the Safety, Tolerability of HH-003 Injection in Participants With Chronic Hepatitis B Virus Infection","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"Huahui Health","has_results":false},{"nct_id":"NCT05851261","title":"Study to Evaluate the Safety, Tolerance, Pharmacokinetics Characteristics of PA3670 Tablets in Chinese Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Zhejiang Palo Alto Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT03664518","title":"to Evaluate the Efficacy and Safety of Eltrombopag for Immune Thrombocytopenia With Chronic HBV Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT06029634","title":"Effects of T-bet B Cells in Persistent Virus Control After Discontinuance of NAs in CHB Patients","phase":"","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT05019040","title":"Study of the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Characteristics of PA1010 in HBV Patients","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Zhejiang Palo Alto Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT04470388","title":"A Study of EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on Treatment","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Enanta Pharmaceuticals, Inc","has_results":false}],"total":21},"guidelines":[],"source":"Drug Landscape verified database"}